Public Charity

MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM

MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM is a Public Charity headquartered in SUMMERVILLE, SC. Financial data from the 2024 filing: $234.5M revenue, $233.0M expenses, $89.2M total assets. 5 publicly reported grants to this organization, totaling roughly $700K, appear in IRS filings.

EIN: 474960128 SUMMERVILLE, SC Latest filing: 2024
Total Revenue$234.5M
Total Expenses$233.0M
Total Assets$89.2M
Grant Records5
Funding Total$700K
Filing Years2020–2024

Mission

TO ASSIST THE UNITED STATES ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND AND OTHER FUNDING SPONSORS BY PROVIDING CUTTING-EDGE TECHNOLOGIES AND EFFECTIVE MATERIEL LIFE-CYCLE MANAGEMENT TO TRANSITION MEDICAL SOLUTIONS THAT PROTECT, TREAT AND OPTIMIZE THE HEALTH AND PERFORMANCE OF US SERVICE MEMBERS ACROSS THE FULL SPECTRUM OF MILITARY OPERATIONS.

Sample Grants Received

2024
ALZHEIMER'S DISEASE RESEARCH ENTITLED: CA2025003
$100,000
2023
Objective Dynamic and 3D Knee Assessment Medical Device to Improve Recovery and Accelerate Return to Readiness of Members with Knee Pain
$50,000
2023
Dynamic Gait-Synchronous Neuromuscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction
$50,000
2020
ALZHEIMER'S DISEASE RESEARCH ENTITLED: (CA2021014)
$250,000
2020
ALZHEIMER'S DISEASE RESEARCH ENTITLED: (CA2021015)
$250,000

Showing up to 5 of 5 total records — full history available with membership.

Officers & Directors

Director Amy Salzhauer
Director Christopher Hlubb
Chief of Strategy and Business Development (Begin 05/2024) Christopher T Steele
Director Dr Andrew Omidvar
Director (Thru 03/2024) Dr Kent Kester
Chief Science Officer Dr Lauren Palestrini

Officer compensation and complete director data available with membership.

Top Grant Purposes

ALZHEIMER'S DISEASE RESEARCH ENTITLED: (CA2021014)
$250,000 1 grant
ALZHEIMER'S DISEASE RESEARCH ENTITLED: (CA2021015)
$250,000 1 grant
ALZHEIMER'S DISEASE RESEARCH ENTITLED: CA2025003
$100,000 1 grant
Dynamic Gait-Synchronous Neuromuscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction
$50,000 1 grant
Objective Dynamic and 3D Knee Assessment Medical Device to Improve Recovery and Accelerate Return to Readiness of Members with Knee Pain
$50,000 1 grant

Financial Trends

Year Revenue Expenses Assets
2024 $234.5M $233.0M $89.2M
2023 $210.5M $210.5M $79.2M
2022 $145.6M $146.3M $98.3M
2021 $159.8M $156.3M $73.2M
2020 $80.4M $77.6M $83.4M

Between 2020 and 2024, reported annual revenue grew from $80.4M to $234.5M (+192%), with total assets most recently reported at $89.2M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM

Complete financials, all 5 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 498,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time